144 related articles for article (PubMed ID: 24760449)
1. Isothermal microcalorimetry of pressurized systems I: a rapid method to evaluate pressurized metered dose inhaler formulations.
D'Sa DJ; Lechuga-Ballesteros D; Chan HK
Pharm Res; 2014 Oct; 31(10):2716-23. PubMed ID: 24760449
[TBL] [Abstract][Full Text] [Related]
2. Isothermal calorimetry: a predictive tool to model drug-propellant interactions in pressurized metered dose systems.
Ooi J; Gaisford S; Boyd BJ; Young PM; Traini D
Int J Pharm; 2014 Jan; 461(1-2):301-9. PubMed ID: 24325938
[TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind, double-dummy, single-dose, efficacy crossover trial comparing formoterol-HFA (pMDI) versus formoterol-DPI (Aerolizer) and placebo (pMDI or Aerolizer) in asthmatic patients.
Bousquet J; Huchon G; Leclerc V; Vicaut E; Lefrançois G
Respiration; 2005; 72 Suppl 1():6-12. PubMed ID: 15915007
[TBL] [Abstract][Full Text] [Related]
4. In vitro investigation of the effect of ambient humidity on regional delivered dose with solution and suspension MDIs.
Shemirani FM; Hoe S; Lewis D; Church T; Vehring R; Finlay WH
J Aerosol Med Pulm Drug Deliv; 2013 Aug; 26(4):215-22. PubMed ID: 23094687
[TBL] [Abstract][Full Text] [Related]
5. Double-blind, double-dummy, multinational, multicenter, parallel-group design clinical trial of clinical non-inferiority of formoterol 12 microg/unit dose in a b.i.d. regimen administered via an HFA-propellant-pMDI or a dry powder inhaler in a 12-week treatment period of moderate to severe stable persistent asthma in adult patients.
Dusser D; Vicaut E; Lefrançois G;
Respiration; 2005; 72 Suppl 1():20-7. PubMed ID: 15915009
[TBL] [Abstract][Full Text] [Related]
6. Humidity affects the morphology of particles emitted from beclomethasone dipropionate pressurized metered dose inhalers.
Ivey JW; Bhambri P; Church TK; Lewis DA; McDermott MT; Elbayomy S; Finlay WH; Vehring R
Int J Pharm; 2017 Mar; 520(1-2):207-215. PubMed ID: 28167262
[TBL] [Abstract][Full Text] [Related]
7. Isothermal microcalorimetry of pressurized systems II: effect of excipient and water ingress on formulation stability of amorphous glycopyrrolate.
D'Sa DJ; Lechuga-Ballesteros D; Chan HK
Pharm Res; 2015 Feb; 32(2):714-22. PubMed ID: 25193129
[TBL] [Abstract][Full Text] [Related]
8. Metered-dose inhaler formulations with beclomethasone-17,21-dipropionate using the ozone friendly propellant R 134a.
Steckel H; Müller BW
Eur J Pharm Biopharm; 1998 Jul; 46(1):77-83. PubMed ID: 9700025
[TBL] [Abstract][Full Text] [Related]
9. Moisture uptake and its influence on pressurized metered-dose inhalers.
Williams RO; Hu C
Pharm Dev Technol; 2000; 5(2):153-62. PubMed ID: 10810745
[TBL] [Abstract][Full Text] [Related]
10. Differences in physical chemistry and dissolution rate of solid particle aerosols from solution pressurised inhalers.
Buttini F; Miozzi M; Balducci AG; Royall PG; Brambilla G; Colombo P; Bettini R; Forbes B
Int J Pharm; 2014 Apr; 465(1-2):42-51. PubMed ID: 24491530
[TBL] [Abstract][Full Text] [Related]
11. The influence of initial atomized droplet size on residual particle size from pressurized metered dose inhalers.
Sheth P; Stein SW; Myrdal PB
Int J Pharm; 2013 Oct; 455(1-2):57-65. PubMed ID: 23911912
[TBL] [Abstract][Full Text] [Related]
12. A Review of Methods for Evaluating Particle Stability in Suspension Based Pressurized Metered Dose Inhalers.
D'Sa D; Chan HK
Curr Pharm Des; 2015; 21(27):3955-65. PubMed ID: 26290200
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of budesonide/formoterol in one hydrofluoroalkane pressurized metered-dose inhaler in patients with chronic obstructive pulmonary disease: results from a 1-year randomized controlled clinical trial.
Rennard SI; Tashkin DP; McElhattan J; Goldman M; Ramachandran S; Martin UJ; Silkoff PE
Drugs; 2009; 69(5):549-65. PubMed ID: 19368417
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind, double-dummy, single-dose, crossover trial evaluating the efficacy and safety profiles of two dose levels (12 and 24 microg) of formoterol-HFA (pMDI) vs. those of a dose level (24 microg) of formoterol-DPI (Foradil/Aerolizer) and of placebo (pMDI or Aerolizer) in moderate to severe asthmatic patients.
Bousquet J; Guenolé E; Duvauchelle T; Vicaut E; Lefrançois G
Respiration; 2005; 72 Suppl 1():13-9. PubMed ID: 15915008
[TBL] [Abstract][Full Text] [Related]
15. Performance of pressurized metered-dose inhalers at extreme temperature conditions.
Morin CMD; Ivey JW; Titosky JTF; Suderman JD; Olfert JS; Vehring R; Finlay WH
J Pharm Sci; 2014 Nov; 103(11):3553-3559. PubMed ID: 25252183
[TBL] [Abstract][Full Text] [Related]
16. The effect of actuator nozzle designs on the electrostatic charge generated in pressurised metered dose inhaler aerosols.
Chen Y; Young PM; Fletcher DF; Chan HK; Long E; Lewis D; Church T; Traini D
Pharm Res; 2015 Apr; 32(4):1237-48. PubMed ID: 25270573
[TBL] [Abstract][Full Text] [Related]
17. Characterization of suspension-based metered dose inhaler formulations composed of spray-dried budesonide microcrystals dispersed in HFA-134a.
Tarara TE; Hartman MS; Gill H; Kennedy AA; Weers JG
Pharm Res; 2004 Sep; 21(9):1607-14. PubMed ID: 15497686
[TBL] [Abstract][Full Text] [Related]
18. Multimodal particle size distributions emitted from HFA-134a solution pressurized metered-dose inhalers.
Smyth HD; Hickey AJ
AAPS PharmSciTech; 2003; 4(3):E38. PubMed ID: 14621970
[TBL] [Abstract][Full Text] [Related]
19. Computational analyses of a pressurized metered dose inhaler and a new drug-aerosol targeting methodology.
Kleinstreuer C; Shi H; Zhang Z
J Aerosol Med; 2007; 20(3):294-309. PubMed ID: 17894536
[TBL] [Abstract][Full Text] [Related]
20. On the Feasibility of Rugose Lipid Microparticles in Pressurized Metered Dose Inhalers with Established and New Propellants.
Minootan Z; Wang H; Connaughton P; Lachacz K; Carrigy N; Ordoubadi M; Lechuga-Ballesteros D; Martin AR; Vehring R
AAPS PharmSciTech; 2024 Apr; 25(4):82. PubMed ID: 38600288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
